Table 2 Hazard ratio for needling procedure success after 12 months
Study factor | Category | Hazard Ratio | 95% Confidence Interval | p |
|---|---|---|---|---|
Group | Control | 1 | ||
Ripasudil | 1.26 | 0.25–6.47 | 0.78 | |
Age | < 65 years | 1 | ||
≥ 65 years | 0.37 | 0.07–4.33 | 0.24 | |
Lens status | Phakia | 1 | ||
IOL | 1.02 | 0.24–4.33 | 0.98 | |
Period between trabeculectomy to needling | < 4 months | 1 | ||
≥ 4 months | 0.26 | 0.03–2.11 | 0.21 | |
IOP before needling | < 18 mmHg | 1 | ||
≥ ≧18 mmHg | 0.70 | 0.15–3.22 | 0.65 | |
Number of antihypertensive medications before needling | < 1 | 1 | ||
≥ 1 | 2.16 | 0.27–17.12 | 0.47 | |
Instilled ripasudil before needling | Ripasudil | 1 | ||
Other or none | 3.64 | 0.38–34.87 | 0.26 | |
Anti-inflammatory eye drops after needling | Betamethasone | 1 | ||
Fluorometholone | 3.15 | 0.31–31.59 | 0.33 |